There are currently millions of adults and children around the world suffering with severe disabilities resulting from traumatic spinal cord injuries (SCI). It is estimated there are more than 180,000 new SCI cases worldwide each year with up to 400 SCIs per year in Australia alone. A common public misconception is that sports activities account for the majority of SCIs, however studies show that the two leading causes are traffic accidents (47%) and falls in persons 65 years of age and older (27%). We are therefore all at risk. Despite advances in rehabilitative medicine, the quality of life for patients who survive a severe spinal cord injury is poor. At present there are no clinically approved interventions that can promote significant recovery of spinal function after SCI – particularly for patients with long-term chronic injuries.
The goal of the Florey Spinal Cord Regeneration Program is the development of new therapies for the traumatically injured or diseased central nervous system (brain and spinal cord) with a primary focus on treatment of long-term chronic spinal cord injury. Promoting regeneration of severed nerve fibres, eliminating scar tissue and stimulating the formation of new neural circuits, “neuroplasticity”, are areas of particular scientific interest with potential benefits for treating a wide variety of neurological disorders. Through conducting basic research of the fundamental biology of the injured central nervous system, the SCR program is pursuing the development of clinically relevant technologies that can be readily translated from the lab to clinical trials in the near future.
If you are seeking more information on living with a spinal injury please follow the link below.